Product :
tomivosertib eFT508
Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
Chemical Information
Product name:tomivosertib eFT508 |
Purity:98% min |
CAS NO:1849590-01-7 |
Solubility:Soluble in DMSO |
Molecular Formula:C17H20N6O2 |
Package:Package according to customer requirements |
Molecular Weight:340.38 |
Storage:Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Remarks
eFT508 has a half-maximal inhibitory concentration (IC50) of 1-2 nM against both MNK isoforms in enzyme assays and inhibits the kinase through a reversible, ATP-competitive mechanism of action. Treatment of tumor cell lines with eFT508 leads to a dose-dependent reduction in eIF4E phosphorylation at serine 209 (IC50 = 2-16 nM). In a panel of ~50 hematological cancers, eFT508 shows anti-proliferative activity against multiple DLBCL cell lines. Sensitivity to eFT508 in TMD8, OCI-Ly3 and HBL1 DLBCL cell lines is associated with dose-dependent decreases in production of pro-inflammatory cytokines including TNFα, IL-6, IL-10 and CXCL10.